9871 related articles for article (PubMed ID: 17210103)
1. [Induction and mechanism study of anti-melanoma immune response by M. tuberculosis Ag85B].
Wu XZ; Wei HM; Zheng XD; Jin TC; Tian ZG
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jan; 23(1):36-8. PubMed ID: 17210103
[TBL] [Abstract][Full Text] [Related]
2. [The estimation of protective efficacy of the fusion gene vaccine encoding tubercle antigen 85B and MPT64 in mice challenged with Mycobacterium tuberculosis].
Luo XD; Zhu DY; Jiang S; Chen Q; Jiang Y
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(8):687-91. PubMed ID: 15130316
[TBL] [Abstract][Full Text] [Related]
3. [Construction of Ag85B DNA vaccine for Mycobacterium tuberculosis and its immunogenicities].
You L; Zhao Y; Gao C
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Dec; 24(12):736-9. PubMed ID: 11930703
[TBL] [Abstract][Full Text] [Related]
4. The Ag85B protein of Mycobacterium tuberculosis may turn a protective immune response induced by Ag85B-DNA vaccine into a potent but non-protective Th1 immune response in mice.
Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Orefici G; Fattorini L; Cassone A
Cell Microbiol; 2007 Jun; 9(6):1455-65. PubMed ID: 17250590
[TBL] [Abstract][Full Text] [Related]
5. [Inhibitory effect of 4-1BBL combined with Hsp70-tumor antigen peptides on pulmonary metastasis of melanoma in mice].
Qiu H; Zhang GM; Zhang H; Yuan Y; Li D; Feng ZH
Ai Zheng; 2005 Jul; 24(7):781-6. PubMed ID: 16004800
[TBL] [Abstract][Full Text] [Related]
6. [Immune response and protective efficacy induced by fusion protein ESAT6-CFP10 of M.tuberculosis in mice].
Zhang H; Shi CH; Xue Y; Bai YL; Wang LM; Xu ZK
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):443-6. PubMed ID: 16806004
[TBL] [Abstract][Full Text] [Related]
7. [Immunopotentiation of novel adjuvant SWZY on the poorly immunogenic murine melanoma vaccine].
Zhou Y; Qi X; Xiao JX; Lai BC; Si LS; Wang YL
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jul; 22(4):526-9. PubMed ID: 16806024
[TBL] [Abstract][Full Text] [Related]
8. A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice.
Liu S; Gong Q; Wang C; Liu H; Wang Y; Guo S; Wang W; Liu J; Shao M; Chi L; Zhao K; Wang Z; Shi Y; Huang Y; Guli A; Zhang C; Kong X
Immunol Lett; 2008 May; 117(2):136-45. PubMed ID: 18339431
[TBL] [Abstract][Full Text] [Related]
9. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
[TBL] [Abstract][Full Text] [Related]
10. [Studies on mechanism of protective immunity against infection of Schistosoma japonicum induced by Sj26 gene transfected dendritic cell].
Shen DW; Luo JP; Li YL; Liu WQ; Long XC
Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Feb; 25(1):17-21. PubMed ID: 17639693
[TBL] [Abstract][Full Text] [Related]
11. [T-bet gene modified dendritic cells abrogate and reverse the airway inflammation in allergic asthma: experiment with mice].
Liu GL; Shi JH; Lin YG; Lu SD; Lin JT
Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(8):519-23. PubMed ID: 19567069
[TBL] [Abstract][Full Text] [Related]
12. Early events of electroporation-mediated intramuscular DNA vaccination potentiate Th1-directed immune responses.
Grønevik E; Mathiesen I; Lømo T
J Gene Med; 2005 Sep; 7(9):1246-54. PubMed ID: 15822067
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effect of pEgr-interferon-gamma-endostatin gene-radiotherapy in mice bearing Lewis lung carcinoma and its mechanism.
Yang W; Li XY
Chin Med J (Engl); 2005 Feb; 118(4):296-301. PubMed ID: 15740667
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y
J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438
[TBL] [Abstract][Full Text] [Related]
15. Experimental study of specific immunotherapy induced by H22 autologous tumor as whole tumor cell vaccine.
Yang W; Guo C; Liu QG; Pan C
Biomed Pharmacother; 2009 Jul; 63(6):404-8. PubMed ID: 18849136
[TBL] [Abstract][Full Text] [Related]
16. Relationship between type 1/type 2 immune responses and occurrence of vertical transmission in BALB/c mice infected with Neospora caninum.
Kano R; Masukata Y; Omata Y; Kobayashi Y; Maeda R; Saito A
Vet Parasitol; 2005 Apr; 129(1-2):159-64. PubMed ID: 15817216
[TBL] [Abstract][Full Text] [Related]
17. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
18. Combining tumor-targeted superantigens with interferon-alpha results in synergistic anti-tumor effects.
Sundstedt A; Celander M; Hedlund G
Int Immunopharmacol; 2008 Mar; 8(3):442-52. PubMed ID: 18279798
[TBL] [Abstract][Full Text] [Related]
19. Combined IFN-gamma-endostatin gene therapy and radiotherapy attenuates primary breast tumor growth and lung metastases via enhanced CTL and NK cell activation and attenuated tumor angiogenesis in a murine model.
Liu LL; Smith MJ; Sun BS; Wang GJ; Redmond HP; Wang JH
Ann Surg Oncol; 2009 May; 16(5):1403-11. PubMed ID: 19263173
[TBL] [Abstract][Full Text] [Related]
20. Fusion protein Ag85B-MPT64(190-198)-Mtb8.4 has higher immunogenicity than Ag85B with capacity to boost BCG-primed immunity against Mycobacterium tuberculosis in mice.
Luo Y; Wang B; Hu L; Yu H; Da Z; Jiang W; Song N; Qie Y; Wang H; Tang Z; Xian Q; Zhang Y; Zhu B
Vaccine; 2009 Oct; 27(44):6179-85. PubMed ID: 19712772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
